Sutter East Bay Medical Foundation Report issue

Foundation Phase 2

Organization Overview

First Clinical Trial
2005
NCT00109161
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now